Literature DB >> 21352075

Prevalence and characteristics of ertapenem-resistant Klebsiella pneumoniae isolates in a Taiwanese university hospital.

Jiunn-Jong Wu1, Li-Rong Wang, Yi-Fang Liu, Hung-Mo Chen, Jing-Jou Yan.   

Abstract

This study was conducted to investigate the prevalence and characteristics of ertapenem-resistant (ETP-R) Klebsiella pneumoniae isolates at a Taiwanese hospital. The disk-diffusion tests revealed that the rate of ertapenem resistance among all isolates collected in 2008 was 13.5%, and the resistance rate among bloodstream isolates increased from 0% to 13.6% between 2001 and 2008. Eighty-two nonduplicate ETP-R isolates collected in 2008 were examined. Seventy-four (90.2%) isolates of them had extended-spectrum β-lactamases (CTX-M- and SHV-type), AmpC enzymes (DHA-1 and CMY-2), and IMP-8 metallo-β-lactamase alone or in combination, and an extremely high prevalence of fluoroquinolone resistance (95.1%) and plasmid-mediated quinolone resistance determinants (90.2%) were also observed. Eighteen ETP-R but imipenem-susceptible isolates were selected and compared with 18 imipenem-nonsusceptible isolates collected before 2008. Sequence analyses revealed genetic disruptions of OmpK36 in 11 imipenem-nonsusceptible and 6 imipenem-susceptible isolates, respectively, and OmpK35 disruptions in 10 isolates for both groups. For the isolates with intact ompK36, sodium dodecyl sulfate-polyacrylamide gel electrophoresis suggests decreased expression of OmpK36 in 5 of 7 imipenem-nonsusceptible isolates and 3 of 12 imipenem-susceptible isolates. In conclusion, the increasing prevalence of ertapenem resistance that was predominantly attributed to noncarbapenemase-mediated resistance mechanisms in K. pneumoniae is becoming a serious treat to patients in Taiwan.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352075     DOI: 10.1089/mdr.2010.0115

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  11 in total

1.  Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae.

Authors:  Alex Agyekum; Alicia Fajardo-Lubián; Xiaoman Ai; Andrew N Ginn; Zhiyong Zong; Xuejun Guo; John Turnidge; Sally R Partridge; Jonathan R Iredell
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

2.  Characterization of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream isolates at a Taiwanese hospital: clinical impacts of lowered breakpoints for carbapenems.

Authors:  N Y Lee; J J Wu; S H Lin; W C Ko; L H Tsai; J J Yan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-18       Impact factor: 3.267

3.  Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant.

Authors:  Aggeliki Poulou; Evangelia Voulgari; Georgia Vrioni; Vasiliki Koumaki; Grigorios Xidopoulos; Vasiliki Chatzipantazi; Fani Markou; Athanassios Tsakris
Journal:  J Clin Microbiol       Date:  2013-07-12       Impact factor: 5.948

4.  Bloodstream infections caused by IMP-8-producing Enterobacteriaceae isolates: the need for clinical laboratory detection of metallo-β-lactamases?

Authors:  J J Yan; N Y Lee; H M Chen; M C Wang; W C Ko; L H Tsai; J J Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-23       Impact factor: 3.267

5.  Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin.

Authors:  Cornelius J Clancy; Liang Chen; Jae H Hong; Shaoji Cheng; Binghua Hao; Ryan K Shields; Annie N Farrell; Yohei Doi; Yanan Zhao; David S Perlin; Barry N Kreiswirth; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

6.  Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.

Authors:  Jocelyn Teo; Yiying Cai; Sarah Tang; Winnie Lee; Thean Yen Tan; Thuan Tong Tan; Andrea Lay-Hoon Kwa
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

7.  In Vitro Activity of Imipenem and Colistin against a Carbapenem-Resistant Klebsiella pneumoniae Isolate Coproducing SHV-31, CMY-2, and DHA-1.

Authors:  Hung-Jen Tang; Yee-Huang Ku; Mei-Feng Lee; Yin-Ching Chuang; Wen-Liang Yu
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

8.  Associations of the major international high-risk resistant clones and virulent clones with specific ompK36 allele groups in Klebsiella pneumoniae in Taiwan.

Authors:  J J Yan; M C Wang; P X Zheng; L H Tsai; J J Wu
Journal:  New Microbes New Infect       Date:  2015-02-09

9.  Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital.

Authors:  Darunee Chotiprasitsakul; Sirawat Srichatrapimuk; Suppachok Kirdlarp; Alexander D Pyden; Pitak Santanirand
Journal:  Infect Drug Resist       Date:  2019-02-20       Impact factor: 4.003

10.  The Metabolome of Carbapenem-Resistant Klebsiella pneumoniae Infection in Plasma.

Authors:  Zhongwei Wen; Mei Liu; Dong Rui; Xiaoxiao Liao; Rui Su; Zhenming Tang; Zhineng Wen; Zhougui Ling
Journal:  Dis Markers       Date:  2021-10-22       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.